BRIEF-Proteostasis Receives Endorsement From Cystic Fibrosis Foundation For Study Of PTI-428 In CF Subjects On Background Symdeko Therapy
April 17, 2018 at 08:08 AM EDT
* PROTEOSTASIS RECEIVES ENDORSEMENT FROM THE CYSTIC FIBROSIS FOUNDATION'S THERAPEUTIC DEVELOPMENT NETWORK FOR THE STUDY OF THE COMPANY'S AMPLIFIER, PTI-428, IN CF SUBJECTS ON BACKGROUND SYMDEKO™ THERAPY Source text for Eikon: Further company coverage:
